We show that Dectin-1 signaling rather promotes the development of colorectal tumors by enhancing the production of prostaglandin E2 (PGE2), which facilitates CRC development and suppresses the expression of tumor-inhibitory IL-22-binding protein (IL-22BP). The gene discussed is IL22RA2; the disease is colorectal carcinoma.